AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript May 2, 2024 AtriCure, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to AtriCure’s First Quarter 2024 Earnings Conference Call. This call is being recorded for replay […]
A small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers.
Lidocaine injections into the greater occipital nerve relieve severe, refractory migraine attacks in children, results of a randomized controlled trial showed.